NEW YORK (GenomeWeb News) – WaferGen Bio-systems reported in its 10-K filing with the US Securities and Exchange Commission this week that its fourth-quarter 2008 revenues fell 60 percent, following three successive quarters of significant increases in revenue.

The Fremont, Calif.-based firm brought in revenues of $65,424 for the three-month period ended Dec. 31, 2008, compared to $161,513 for the comparable period the year before. It did not provide a reason in the filing for the sharp year-over-year decline.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.